COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Transgene launches a fundraising campaign for approximately 105 million euros
Transgene launches a fundraising of approximately 105 million euros through new share issuance to investors. Funding to advance myvac program for personalized cancer vaccines and ensure financial stability until early 2028 -
-
-
COMMUNIQUÉ DE PRESSE
Transgene to Showcase Potential of Proprietary VacDesignR® Computational Tool to Optimize Individualized Therapeutic Cancer Vaccines
Transgene to present VacDesignR® tool at ESMO-AI 2025 for optimized cancer vaccine design. Tool enhances virus efficiency and yield for individualized therapies -
-
-
-
COMMUNIQUÉ DE PRESSE
Transgene fait le point sur ses activités et sa situation financière au troisième trimestre 2025
Transgene fait le point sur ses activités et sa situation financière au troisième trimestre 2025, notamment sur les avancées de son vaccin thérapeutique TG4050 contre le cancer de la tête et du cou -
